Physiomics Plc (LON:PYC – Get Free Report) shot up 35.5% during trading on Tuesday . The stock traded as high as GBX 1.10 ($0.01) and last traded at GBX 1.05 ($0.01). 20,006,418 shares changed hands during mid-day trading, an increase of 186% from the average session volume of 7,002,114 shares. The stock had previously closed at GBX 0.78 ($0.01).
Physiomics Stock Performance
The firm has a 50 day simple moving average of GBX 0.72 and a 200 day simple moving average of GBX 0.72. The firm has a market cap of £2.13 million, a P/E ratio of -13.83 and a beta of 1.69.
Insider Activity
In other Physiomics news, insider Peter Sargent purchased 459,090 shares of the stock in a transaction on Thursday, November 7th. The shares were purchased at an average price of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,617.84). 4.18% of the stock is owned by company insiders.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Featured Articles
- Five stocks we like better than Physiomics
- Comparing and Trading High PE Ratio Stocks
- Is a Ford Stock Turnaround on the Horizon?
- How to Calculate Stock Profit
- What PMI Data Says About the NFP Report: 3 Hidden Opportunities
- How to Short a Stock in 5 Easy Steps
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
